Impact of Pulmonary Rehabilitation on Direct Healthcare Costs in Chronic Obstructive Pulmonary Disease (COPD)
This study has been completed.
Sponsor:
East and North Hertfordshire NHS Trust
Information provided by (Responsible Party):
Indranil Chakravorty, East and North Hertfordshire NHS Trust
ClinicalTrials.gov Identifier:
NCT01545128
First received: March 1, 2012
Last updated: March 5, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to study the direct cost of illness study of COPD patients who participated in a Pulmonary rehabilitation program for 8 weeks.
| Condition |
|---|
|
COPD |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | A Retrospective Case-control Study Comparing the Direrct Healthcare Costs of Conventionally Managed COPD Patients With Those Who Have Completed a Pulmonary Rehabilitation Programme |
Resource links provided by NLM:
Further study details as provided by East and North Hertfordshire NHS Trust:
Eligibility| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
copd
Criteria
Inclusion Criteria:
- COPD
Exclusion Criteria:
- None
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| Responsible Party: | Indranil Chakravorty, Consultant Physician, East and North Hertfordshire NHS Trust |
| ClinicalTrials.gov Identifier: | NCT01545128 History of Changes |
| Other Study ID Numbers: | 07/H0311/87 |
| Study First Received: | March 1, 2012 |
| Last Updated: | March 5, 2012 |
| Health Authority: | United Kingdom: Research Ethics Committee |
Keywords provided by East and North Hertfordshire NHS Trust:
|
COPD Pulmonary rehabilitation |
Additional relevant MeSH terms:
|
Lung Diseases Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on June 18, 2013